BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 16, 2016
View Archived Issues
FDA grants QIDP designation to Amplyx Pharmaceuticals' APX-001
Read More
Bone Biologics signs agreement with UCLA to license Nell-1 for osteoporosis
Read More
QIAGEN launches QIAsure Methylation Test for cervical cancer
Read More
alpha-Synuclein specifically binds to TOM20 and inhibits mitochondrial protein import in human PD
Read More
Novel tracer targeting thymidine phosphorylase tested for the first time in humans
Read More
BARDA awards next option on contract to Atox Bio to support development of AB-103
Read More
PeptiDream earns milestone for the dosing of first patient in BMS clinical trial
Read More
Flex Pharma starts phase II study for FLX-787
Read More
Multilisa BICD2 test receives CE Mark
Read More
Roche patents cathepsin S inhibitors
Read More
Janssen Pharmaceutica discloses mGlu2 receptor negative allosteric modulators
Read More
Novartis expands partnership with MMV for the development of antimalarial compound KAF-156
Read More
Eli Lilly develops AICARFT inhibitors
Read More
Bayer Schering Pharma presents sGC activators
Read More
Aegerion Pharmaceuticals and QLT enter strategic merger agreement
Read More
Merck & Co. announces OX2 receptor antagonists
Read More
MRC Technology and AstraZeneca seek new epigenetic drug targets in respiratory disease
Read More
Oncolys BioPharma announces joint research agreement with Kyoto University
Read More
Argos Therapeutics and Adaptive Biotechnologies enter strategic research agreement
Read More
Zydus Cadila and Eczacibassi Ilac Pazarlama establish biosimilars strategic collaboration in Turkey
Read More
Worse progression-free survival seen in pelareorep treatment group in colorectal cancer trial
Read More
Long-term efficacy and safety of canakinumab
Read More
On-target activity and responses seen with BGB-324 in first study in leukemia patients
Read More
AnGes and Morishita Jintan enter agreement regarding rights to CIN treatment vaccine
Read More
FDA approves expanded label for Glassia
Read More
Apogenix reports topline results from phase I trial of APG-101
Read More
Cellceutix says phase II trial of brilacidin in ulcerative proctitis set to begin this week
Read More
Cibinetide receives two FDA orphan drug designations
Read More
TASP-0434299: a specific radioligand to vasopressin V1B receptor
Read More
